Suppression of CCT3 inhibits the proliferation and migration in breast cancer cells

Cancer Cell International
Gang XuHong Ge

Abstract

CCT3 is a subunit of chaperonin-containing TCP-1 (CCT), which folds many proteins involved in cancer development and plays an important role in many cancers. However, the role of CCT3 in breast cancer is still unclear. CCT3 expression was knocked down by transfecting breast cancer cells with lentiviral shRNA. The proliferation of breast cancer cells (HCC1937 and MDA-MB-231) was detected by Celigo image cytometry and MTT assay, the migration of the cells was measured by Transwell analysis, cell cycle distribution and apoptosis was detected by flow cytometry, and changes in signal transduction proteins were detected by western blot analysis. The expression of CCT3 was significantly suppressed by transduction with lentiviral shRNA; CCT3 knockdown significantly reduced the proliferation and metastasis ability of breast cancer cells (HCC 1937 and MDA-MB-231), increased the proportion of cells in S phase, and decreased the proportion of cells in G1 phase compared to those in shControl cells. There was no significant change in the number of cells in the G2/M phase. Apoptosis analysis showed that knockdown of CCT3 induced apoptosis in breast cancer cells. Western blot analysis showed that the expression of many signal transduction prot...Continue Reading

References

Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H SternlichtM B Yaffe
May 24, 2008·Clinical & Experimental Metastasis·Michael F Olson, Erik Sahai
Apr 24, 2014·PLoS Biology·Moses KasembeliDavid J Tweardy
Nov 18, 2015·Cancer Research·Xuyi WangKristy A Brown
Mar 26, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Rania BassiouniAnnette R Khaled
Apr 28, 2016·Advances in Clinical Chemistry·Charushila Y Kadam, Subodhini A Abhang
Jul 9, 2016·Cancer Cell International·E-Na QianXun Lv
Nov 17, 2016·Current Pharmaceutical Design·Var Ruchi SharmaAnil K Sharma
Oct 19, 2017·Journal of Experimental & Clinical Cancer Research : CR·Ying-Chun ZhangDong-Sheng Pei
Nov 22, 2017·Nature Communications·Federica FusellaMara Brancaccio
May 8, 2018·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Keith R Willison
Jul 23, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F CardosoE P Winer
Oct 26, 2018·The Breast : Official Journal of the European Society of Mastology·Domen RibnikarFatima Cardoso
Jan 23, 2019·JAMA : the Journal of the American Medical Association·Adrienne G Waks, Eric P Winer
Sep 25, 2019·Nature Reviews. Disease Primers·Nadia HarbeckFatima Cardoso

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
flow cytometry
electrophoresis

Software Mentioned

SPSS

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.